Dynatrace and ServiceNow stocks added as BMO top picks
Source: Investing.com

BMO added Dynatrace and ServiceNow to its top software picks, raised both price targets, and maintained Outperform ratings without changing earnings estimates. It cited less demanding near-term setups than Okta’s, while retaining its Outperform view on Okta and its potential for accelerating revenue growth. Other firms have also raised ServiceNow targets to $165–$175, citing AI products, Security demand and business growth; the article gives no new target levels for BMO or share-price reaction.
Analysis
The investable signal is a shift in analyst preference toward DT and NOW as less expectation-heavy setups, not evidence of higher forward earnings: BMO left estimates unchanged. That makes any near-term upside more dependent on positioning and valuation than on a new fundamental forecast. OKTA’s identity-market opportunity may remain intact, but elevated expectations into its October-quarter results create asymmetric event risk if bookings, guidance, or growth deceleration disappoint.
For NOW, repeated target increases and AI enthusiasm risk creating a crowded narrative without a commensurate near-term revenue contribution. Security and ITOM demand are more concrete indicators to test against reported results; contract value is not the same as recognized revenue. High-multiple software also remains exposed to rate-driven multiple compression and enterprise budget scrutiny. DT may benefit from preference rotation, but the article gives no estimates, valuation, or demand data to establish that it is fundamentally safer.
Over days to the next reports, watch estimate revisions and post-earnings reactions rather than target changes. Over 1–3 months, guidance and conversion of AI activity and contract value into recurring revenue are the key catalysts. Over 6–18 months, sustained identity-market shifts and enterprise automation adoption could support growth, while Microsoft and other platform vendors bundling adjacent capabilities could pressure standalone pricing. Contrarian point: the cluster of optimistic targets can amplify disappointment risk; no independent evidence here validates incremental AI monetization. Falsify a cautious view if reported growth, renewals, and guidance accelerate without margin or cash-flow deterioration; a guide-down or weakening demand metrics would validate it.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
Key Decisions for Investors
- Do not trade the target increases alone. Before adding NOW, require evidence in reported subscription growth, renewal trends, and AI-related revenue conversion; reduce exposure if guidance weakens or AI activity fails to translate into recurring revenue.
- Consider a small, event-risk-aware relative position favoring DT over OKTA into OKTA’s October-quarter results, reflecting the cited expectation gap—not a proven valuation advantage. Verify relative valuation, estimate revisions, and positioning first; exit if DT underperforms on guidance or OKTA delivers results that reset expectations higher.
- Keep OKTA exposure sized for an earnings gap: monitor forward guidance and identity-related demand. A guide-down or weaker renewals is the near-term thesis trigger; sustained acceleration would invalidate the cautious event setup.
- Track long-duration software exposure against rate moves and enterprise-spending indicators. Broad multiple compression, independent of company execution, is a portfolio-level risk to NOW, DT, and OKTA.
More News
- AI rally fades away from Wall Street as a tiny IPO makes big waves
- Why is SoftBank stock sliding 6% today?
- Nscale, Anthropic Eye $45 Billion Cloud Deal as AI Trade Rebounds
- Investors hedge AI boom with credit default swaps on tech debt
- Morgan Stanley initiates ADARx stock with overweight rating
- JPMorgan initiates nVent Electric stock coverage with overweight rating
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Reading Conviction in the Tape: What Level 3 Order Book Data Really Tells Discretionary PMs
- AI Tools for CFA Charterholders: An Evidence Standard